Minerva Neurosciences: Q4 Earnings Insights
Portfolio Pulse from Benzinga Insights
Minerva Neurosciences (NASDAQ:NERV) reported Q4 earnings with an EPS of $-1.19, missing estimates by 35.23% and showing no revenue change from the previous year. The company's past earnings miss was followed by a slight share price drop.
February 22, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Minerva Neurosciences reported a significant miss in Q4 earnings with an EPS of $-1.19, missing estimates by 35.23%, and no revenue change from the previous year.
The significant miss in earnings estimates and the lack of revenue growth are likely to negatively impact investor sentiment and could lead to a decrease in the stock price, similar to the previous quarter's earnings miss which resulted in a slight share price drop.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100